Papel del tejidoadiposoblanco,marrónyperivascular…
341
18.
Gastaldelli A, Miyazaki Y, Pettiti M, Matsuda M, Mahankali S, Santini E, et al. Metabolic
effects of visceral fat accumulation in type 2 diabetes. J Clin Endocrinol Metab. 2002;
87(11):5098-‐103.
19.
Marin P, Andersson B, OttossonM, Olbe L, Chowdhury B, Kvist H, et al. The morphology
andmetabolismof intraabdominal adipose tissue inmen. Metabolism.1992; 41(11):1242-‐
1248.
20.
MontagueCT, Prins JB, Sanders L, Digby JE, O'RahillyS. Depot-‐ and sex-‐specificdifferences
inhuman leptinmRNAexpression: implications for the control of regional fat distribution.
Diabetes1997; 46(3):342-‐347.
21.
WajchenbergBL. Subcutaneous andvisceral adipose tissue: their relation to themetabolic
syndrome. EndocrRev2000; 21(6):697-‐738.
22.
Bjorntorp P. Metabolic implications of body fat distribution. Diabetes Care 1991;14
(12):1132-‐1143.
23.
Hellmer J, Marcus C, Sonnenfeld T, Arner P. Mechanisms for differences in lipolysis
between human subcutaneous and omental fat cells. J Clin Endocrinol Metab. 1992;
75(1):15-‐20.
24.
Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of
adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and
subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004;
145(5):2273-‐2282.
25.
SnijderMB, Dekker JM, VisserM, Bouter LM, Stehouwer CD, KostensePJ et al. Associations
of hip and thigh circumferences independent ofwaist circumferencewith the incidence of
type2diabetes: theHoornStudy. AmJ ClinNutr2003; 77(5):1192-‐1197.
26.
Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-‐Horvat P, Liu CY et al. Abdominal
visceral and subcutaneous adipose tissue compartments: associationwithmetabolic risk
factors in theFraminghamHeart Study. Circulation2007; 116(1):39-‐48.
27.
Arner P, Eckel RH. Adipose tissue as storage organ. En: George A. Bray, Claude Bouchard,
WPT. James, editors. HandbookofObesity. 1998:379-‐395.
28.
Wang H, Eckel RH. Lipoprotein lipase: from gene to obesity. Am J Physiol Endocrinol
Metab. 2009; 297(2):E271-‐88.
29.
BessesenDH, Robertson AD, Eckel RH. Weight reduction increases adipose but decreases
cardiac LPL in reduced-‐obese Zucker rats. AmJ Physiol Endocrinol Metab. 1991; 261(2Pt
1): E246–E251.
30.
Eckel RH, Yost TJ. Weight reduction increases adipose tissue lipoprotein lipase
responsiveness inobesewomen. J Clin Invest.1987; 80(4):992–997.
31.
Pollare T, Vessby B, Lithell H. Lipoprotein lipase activity in skeletal muscle is related to
insulinsensitivity. ArteriosclerThromb1991; 11(5):1192–1203.
32.
Sadur CN, Yost TJ, Eckel RH. Insulin responsiveness of adipose tissue lipoprotein lipase is
delayedbut preserved inobesity. J ClinEndocrinolMetab1984; 59(6):1176–1182.
33.
Hartman AD. Lipoprotein lipase activities in adipose tissues and muscle in the obese
Zucker rat. AmJ Physiol EndocrinolMetab1981; 241(2):E108–E115.
34.
Terrettaz J, Cusin I, Etienne J, Jeanrenaud B. In vivo regulation of adipose tissue
lipoprotein lipase in normal rats made hyperinsulinemic and in hyperinsulinemic
genetically-‐obese (fa/fa) rats. Int JObesRelatMetabDisord1994; 18(1): 9–15.
35.
SchwartzRS, Brunzell JD. Increaseof adipose tissue lipoprotein lipase activitywithweight
loss. J Clin Invest 1981; 67(5):1425–1430.
36.
Llorente-‐CebriánS, KulytéA, HedénP, NäslundE, ArnerP, RydénM. Relationshipbetween
site-‐specific HSL phosphorylation and adipocyte lipolysis in obese women. Obes Facts.
2011; 4(5):365-‐71.
37.
LanginD, Dicker A, Tavernier G, Hoffstedt J, Mairal A, RydénM, Arner E, SicardA, Jenkins
CM, ViguerieN, vanHarmelenV, Gross RW, HolmC, Arner P. Adipocyte lipases and defect
of lipolysis inhumanobesity. Diabetes. 2005; 54(11):3190-‐7.
38.
Arner P. Hunting for human obesity genes? Look in the adipose tissue! Int J Obes Relat
MetabDisord. 2000; 24Suppl 4:S57-‐62.
39.
Valet P, GrujicD,Wade J, ItoM, ZingarettiMC, SolovevaVet al. Expressionof humanalpha
2-‐adrenergic receptors in adipose tissue of beta 3-‐adrenergic receptor-‐deficient mice
promotesdiet-‐inducedobesity. JBiol Chem. 2000; 275(44):34797-‐802.
